International Pharmaceutical Aerosol Consortium on Regulation & Science
The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) is an international association that seeks to advance the science, and especially the regulatory science, of orally inhaled and nasal drug products (OINDPs) by collecting and analyzing data, and conducting joint research and development projects. Representing the OINDP industry since 2000, IPAC-RS aims to build consensus and contribute to effective regulations and standards by sharing the results of its research through conferences, technical journals, webinars, and discussions with regulatory bodies.
News and Events
The liability of fine particle dose (FPD) Can we rely on the fine partical dose metric alone for quality control?
April 26, 2020
Digital RDD 2020 and IPAC-RS Symposium- The Global Regulatory Landscape and Advances in Digital Technology: Transforming the OINDP-Patient Experience.
Presentations now posted!
June 5, 2019
2019 IPAC-RS/ISAM Joint Workshop- Digital Health in Inhaled Drug Delivery